Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.

[1]  Y. Momiyama,et al.  Inflammation, Atherosclerosis and Coronary Artery Disease , 2014, Clinical Medicine Insights. Cardiology.

[2]  C. Apovian,et al.  B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile , 2013, Proceedings of the National Academy of Sciences.

[3]  Jongsoon Lee.  Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes , 2013, Archives of pharmacal research.

[4]  A. Chawla,et al.  Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis , 2013, Science.

[5]  R. Flavell,et al.  JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation , 2013, Science.

[6]  P. Libby,et al.  Effects of Interleukin-1&bgr; Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial , 2012, Circulation.

[7]  R. Seong,et al.  A Novel Function of Adipocytes in Lipid Antigen Presentation to iNKT Cells , 2012, Molecular and Cellular Biology.

[8]  J. Orr,et al.  Toll-like Receptor 4 Deficiency Promotes the Alternative Activation of Adipose Tissue Macrophages , 2012, Diabetes.

[9]  K. Oestreich,et al.  Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors , 2012, Nature Reviews Immunology.

[10]  Amin R. Mazloom,et al.  Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages , 2012, Nature Immunology.

[11]  S. Balk,et al.  Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. , 2012, Immunity.

[12]  G. Besra,et al.  Natural killer T cells in adipose tissue prevent insulin resistance. , 2012, The Journal of clinical investigation.

[13]  J. Gugenheim,et al.  Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients , 2012, Diabetes.

[14]  D. Stolz,et al.  Dendritic Cells Promote Macrophage Infiltration and Comprise a Substantial Proportion of Obesity-Associated Increases in CD11c+ Cells in Adipose Tissue and Liver , 2012, Diabetes.

[15]  M. Shiau,et al.  Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4 , 2012, International Journal of Obesity.

[16]  Robert V Farese,et al.  Lipid droplets and cellular lipid metabolism. , 2012, Annual review of biochemistry.

[17]  C. Lumeng,et al.  CX3CR1 Deficiency Does Not Influence Trafficking of Adipose Tissue Macrophages in Mice With Diet‐Induced Obesity , 2012, Obesity.

[18]  Liu Yang,et al.  Short Term High Fat Diet Challenge Promotes Alternative Macrophage Polarization in Adipose Tissue via Natural Killer T Cells and Interleukin-4* , 2012, The Journal of Biological Chemistry.

[19]  C. Glass,et al.  Inflammation and lipid signaling in the etiology of insulin resistance. , 2012, Cell metabolism.

[20]  P. Allavena,et al.  Human Adipose Tissue Macrophages Display Activation of Cancer-related Pathways* , 2012, The Journal of Biological Chemistry.

[21]  S. Akira,et al.  The Radioprotective 105/MD-1 Complex Contributes to Diet-Induced Obesity and Adipose Tissue Inflammation , 2012, Diabetes.

[22]  C. Benoist,et al.  PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells , 2012, Nature.

[23]  Vrajesh V. Parekh,et al.  Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice , 2012, Proceedings of the National Academy of Sciences.

[24]  C. Mauri,et al.  Immune regulatory function of B cells. , 2012, Annual review of immunology.

[25]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[26]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[27]  A. Zychlinsky,et al.  Neutrophil function: from mechanisms to disease. , 2012, Annual review of immunology.

[28]  S. Kersten,et al.  Activation of Natural Killer T Cells Promotes M2 Macrophage Polarization in Adipose Tissue and Improves Systemic Glucose Tolerance via Interleukin-4 (IL-4)/STAT6 Protein Signaling Axis in Obesity* , 2012, The Journal of Biological Chemistry.

[29]  G. Ghosh,et al.  NF‐κB regulation: lessons from structures , 2012, Immunological reviews.

[30]  J. Olefsky,et al.  The cellular and signaling networks linking the immune system and metabolism in disease , 2012, Nature Medicine.

[31]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[32]  E. Ropelle,et al.  Gut Microbiota Is a Key Modulator of Insulin Resistance in TLR 2 Knockout Mice , 2011, PLoS biology.

[33]  F. Radtke,et al.  Mechanisms of T cell development and transformation. , 2011, Annual review of cell and developmental biology.

[34]  M. Gillum,et al.  Impact of CD1d Deficiency on Metabolism , 2011, PloS one.

[35]  M. Merad,et al.  Dendritic cell and macrophage heterogeneity in vivo. , 2011, Immunity.

[36]  L. Joosten,et al.  Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[37]  Michael J. Bevan,et al.  CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.

[38]  V. Jala,et al.  Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-Induced Obesity , 2011, The Journal of Immunology.

[39]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[40]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[41]  O. Ohara,et al.  Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue , 2011, Proceedings of the National Academy of Sciences.

[42]  K. Clément,et al.  Krüppel-like factor 4 regulates macrophage polarization. , 2011, The Journal of clinical investigation.

[43]  T. Kay,et al.  Macrophage Deletion of SOCS1 Increases Sensitivity to LPS and Palmitic Acid and Results in Systemic Inflammation and Hepatic Insulin Resistance , 2011, Diabetes.

[44]  X. Yang,et al.  Mice Lacking NKT Cells but with a Complete Complement of CD8+ T-Cells Are Not Protected against the Metabolic Abnormalities of Diet-Induced Obesity , 2011, PloS one.

[45]  Carey N Lumeng,et al.  Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.

[46]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[47]  H. Roche,et al.  Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet–Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis , 2011, Diabetes.

[48]  D. Clegg,et al.  Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. , 2011, The Journal of clinical investigation.

[49]  Michael N. Alonso,et al.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies , 2011, Nature Medicine.

[50]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[51]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[52]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[53]  G. Hotamışlıgil,et al.  Inflammatory mechanisms in obesity. , 2011, Annual review of immunology.

[54]  M. Febbraio,et al.  Hematopoietic Cell–Restricted Deletion of CD36 Reduces High-Fat Diet–Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue , 2011, Diabetes.

[55]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[56]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[57]  A. Lin,et al.  Selective Inactivation of c-Jun NH2-Terminal Kinase in Adipose Tissue Protects Against Diet-Induced Obesity and Improves Insulin Sensitivity in Both Liver and Skeletal Muscle in Mice , 2011, Diabetes.

[58]  M. Febbraio,et al.  Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice , 2011, Diabetologia.

[59]  R. Locksley,et al.  IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.

[60]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[61]  S. Akira,et al.  Myeloid Differentiation Factor 88 (MyD88)-Deficiency Increases Risk of Diabetes in Mice , 2010, PloS one.

[62]  B. Trigatti,et al.  Interleukin‐15 Contributes to the Regulation of Murine Adipose Tissue and Human Adipocytes , 2010, Obesity.

[63]  M. Karin,et al.  JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[65]  S. Abraham,et al.  Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.

[66]  C. Kahn,et al.  Myeloid Cell-Restricted Insulin Receptor Deficiency Protects Against Obesity-Induced Inflammation and Systemic Insulin Resistance , 2010, PLoS genetics.

[67]  F. Greenway,et al.  Obesity Increases the Production of Proinflammatory Mediators from Adipose Tissue T Cells and Compromises TCR Repertoire Diversity: Implications for Systemic Inflammation and Insulin Resistance , 2010, The Journal of Immunology.

[68]  G. Hotamışlıgil.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[69]  K. Jablonski,et al.  The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes , 2010, Annals of Internal Medicine.

[70]  P. Weller,et al.  Eosinophils and Th2 immunity: contemporary insights , 2010, Immunology and cell biology.

[71]  M. Bogoyevitch,et al.  c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. , 2010, Biochimica et biophysica acta.

[72]  Pilar M. Dominguez,et al.  Differentiation and function of mouse monocyte‐derived dendritic cells in steady state and inflammation , 2010, Immunological reviews.

[73]  K. Strissel,et al.  Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice , 2010, Diabetes.

[74]  H. Tsutsui,et al.  Natural Killer T Cells Are Involved in Adipose Tissues Inflammation and Glucose Intolerance in Diet-Induced Obese Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[75]  H. Shapiro,et al.  Inflammation and adipose tissue macrophages in lipodystrophic mice , 2009, Proceedings of the National Academy of Sciences.

[76]  A. Saltiel,et al.  MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesity , 2009, The Journal of experimental medicine.

[77]  I. Verma,et al.  Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.

[78]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[79]  R. Friedline,et al.  Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle , 2009, Diabetes.

[80]  Christophe Benoist,et al.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters , 2009, Nature Medicine.

[81]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[82]  K. Clément,et al.  Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice , 2009, Nature Medicine.

[83]  E. Renard,et al.  CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. , 2009, Cell metabolism.

[84]  B. Beutler.  TLRs and innate immunity. , 2009, Blood.

[85]  P. Tontonoz,et al.  Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ−/−, PPARδ−/−, PPARγδ−/−, or LXRαβ−/− bone marrow* , 2009, Journal of Lipid Research.

[86]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[87]  J. Olefsky,et al.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. , 2008, Cell metabolism.

[88]  S. Brownell,et al.  Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. , 2008, Cytokine.

[89]  R. Steinman.  Dendritic cells in vivo: a key target for a new vaccine science. , 2008, Immunity.

[90]  G. Hotamisligil,et al.  A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of Systemic Insulin Sensitivity , 2008, PloS one.

[91]  T. Lebien,et al.  B lymphocytes: how they develop and function. , 2008, Blood.

[92]  F. Powrie,et al.  Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans , 2008, The Journal of experimental medicine.

[93]  M. Willingham,et al.  Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of Macrophages* , 2008, Journal of Biological Chemistry.

[94]  Craig Murdoch,et al.  The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.

[95]  C. Kummer,et al.  Blockade of α4 Integrin Signaling Ameliorates the Metabolic Consequences of High-Fat Diet–Induced Obesity , 2008, Diabetes.

[96]  M. Furuhashi,et al.  Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.

[97]  Chih-Hao Lee,et al.  Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. , 2008, Cell metabolism.

[98]  A. Goldfine,et al.  Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes , 2008, Clinical and Translational Science.

[99]  F. Karpe,et al.  Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages , 2008, Circulation.

[100]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[101]  M. Tschöp,et al.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. , 2007, The Journal of clinical investigation.

[102]  A. Ferrante,et al.  Obesity‐induced inflammation: a metabolic dialogue in the language of inflammation , 2007, Journal of internal medicine.

[103]  O. McGuinness,et al.  Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity , 2007 .

[104]  J. Carvalheira,et al.  Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance , 2007, Diabetes.

[105]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[106]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[107]  M. Scadeng,et al.  Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance , 2007, Nature Medicine.

[108]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[109]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[110]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[111]  T. Kadowaki,et al.  Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance* , 2006, Journal of Biological Chemistry.

[112]  J. Capeau,et al.  Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.

[113]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[114]  Carl Nathan,et al.  Neutrophils and immunity: challenges and opportunities , 2006, Nature Reviews Immunology.

[115]  C. Kahn,et al.  From mice to men: insights into the insulin resistance syndromes. , 2006, Annual review of physiology.

[116]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[117]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[118]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[119]  Gennaro De Libero,et al.  Recognition of lipid antigens by T cells , 2005, Nature Reviews Immunology.

[120]  M. Czech,et al.  An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. , 2004, Genes & development.

[121]  L. Van Kaer.  Natural killer T cells as targets for immunotherapy of autoimmune diseases , 2004, Immunology and cell biology.

[122]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[123]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[124]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[125]  M. White.  Insulin Signaling in Health and Disease , 2003, Science.

[126]  Irving L Weissman,et al.  Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.

[127]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[128]  J. Manson,et al.  C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[129]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[130]  K. Garcia,et al.  The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1 , 2002, The Journal of Immunology.

[131]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[132]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[133]  Christian Weyer,et al.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[134]  L. Kuller,et al.  The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. , 2001, Diabetes.

[135]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[136]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[137]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[138]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[139]  G. Panayi,et al.  Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.

[140]  G. Shulman,et al.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.

[141]  H. Macdonald,et al.  Selective Bystander Proliferation of Memory CD4+ and CD8+ T Cells Upon NK T or T Cell Activation , 2000, The Journal of Immunology.

[142]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[143]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[144]  A. Scheen,et al.  No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. , 2000, The Journal of clinical endocrinology and metabolism.

[145]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[146]  Y. Koezuka,et al.  Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. , 1999, Journal of immunology.

[147]  L. Kaer,et al.  Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. , 1999, Journal of immunology.

[148]  Gerardo Heiss,et al.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.

[149]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-α function , 1997, Nature.

[150]  Margaret S. Wu,et al.  Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice , 1997, Diabetes.

[151]  J. Stephens,et al.  Tumor Necrosis Factor-α-induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Substrate-1 and GLUT4 Expression without a Loss of Insulin Receptor-mediated Signal Transduction* , 1997, The Journal of Biological Chemistry.

[152]  Roy Taylor,et al.  Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM , 1996, Diabetes.

[153]  J. Stephens,et al.  Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. , 1992, The Journal of biological chemistry.

[154]  M. Ruth.  Normalization of obesity-associated insulin resistance through immunotherapy , 2010 .

[155]  O. McGuinness,et al.  Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. , 2007, American journal of physiology. Endocrinology and metabolism.

[156]  M. Tsai,et al.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.

[157]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[158]  R. de Caterina,et al.  From asthma to atherosclerosis--5-lipoxygenase, leukotrienes, and inflammation. , 2004, The New England journal of medicine.

[159]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[160]  J. Barzilay,et al.  Inflammation and its Association with Glucose Disorders and Cardiovascular Disease , 2003, Treatments in endocrinology.

[161]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[162]  E. Ford.  Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults. , 2002, American journal of epidemiology.

[163]  K. Garcia,et al.  The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. , 2002, Journal of immunology.

[164]  J. Kolls,et al.  An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. , 1998, Endocrinology.

[165]  J. Stephens,et al.  Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. , 1997, The Journal of biological chemistry.

[166]  K. Uysal,et al.  Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. , 1997, Nature.

[167]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[168]  R. Roth,et al.  The insulin receptor family. , 1993, Advances in experimental medicine and biology.

[169]  M. Peters.  The eosinophil. , 1987, Advances in dermatology.

[170]  P. Libby,et al.  Interferon- (cid:1) , a Th1 Cytokine, Regulates Fat Inflammation A Role for Adaptive Immunity in Obesity , 2022 .

[171]  J. Tanti,et al.  Interleukin-1 (cid:1) -Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression , 2022 .